⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8704714 | 1.00 | — | — | |
| SCHEMBL3380324 | 1.00 | — | — | |
| SCHEMBL13181746 | 0.82 | — | — | |
| SCHEMBL10210663 | 0.82 | — | — | |
| SCHEMBL13577927 | 0.81 | — | — | |
| SCHEMBL13907321 | 0.81 | — | — | |
| SCHEMBL8497429 | 0.80 | CD274 (0.34) | — | |
| SCHEMBL8497430 | 0.80 | CD274 (0.34) | — | |
| SCHEMBL29858530 | 0.78 | TP53 (0.47) | — | |
| SCHEMBL12295331 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3991107-A | Haloamine transfer | NATIONAL PATENT DEVELOPMENT CORPORATION (US) | 1976-11-09 | — | — | US | claimed |
| CN-116710046-A | Phosphonic acid and N-halamine compositions for tartar removal | O.Y.M.创新有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-11207416-B2 | Compositions and methods for targeted RNA delivery | VERVE THERAPEUTICS, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | disclosed |
| US-7387888-B2 | obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell | MONTANA STATE UNIVERSITY (US) | 2008-06-17 | — | — | US | disclosed |
| US-20050260182-A1 | obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell | MONTANA STATE UNIVERSITY | 2005-11-24 | — | — | US | disclosed |
| WO-2003025005-A2 | PURIFIED BACTERIAL POLYPEPTIDES INVOLVED IN PROTEIN PROCESSING | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2003-03-27 | — | — | WO | disclosed |
| EP-1173473-A1 | ANTIFUNGAL AGENTS ISOLATED FROM PSEUDOMONAS SYRINGAE | ELI LILLY AND COMPANY (US) | 2002-01-23 | — | — | EP | disclosed |
| US-6310037-B1 | ADMINISTERING TO MAMMAL A SYRINGOMYCIN LIPODEPSIPEPTIDE IN AN AMOUNT SUFFICIENT TO INTERFERE WITH THE PROTOZOAL INFECTION | UTAH STATE UNIVERSITY | 2001-10-30 | — | — | US | disclosed |
| WO-2000063240-A1 | ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) | ELI LILLY AND COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| US-5981264-A | PURE MICROORGANISM CULTURES PRODUCING FUNGICIDES; FOR TREATMENT OF PLANT DISEASE OR EFFECTIVE AS USE AS HERBICIDES | THE RESEARCH AND DEVELOPMENT INSTITUTE, INC. AT MONTANA STATE UNIVERSITY (US) | 1999-11-09 | — | — | US | disclosed |
| US-5837685-A | PSEUDOMYCIN | RESEARCH AND DEVELOPMENT INSTITUTE INC. AT MONTANA STATE UNIVERSITY (US) | 1998-11-17 | — | — | US | disclosed |
| US-5576298-A | PSEUDOMYCIN | RESEARCH AND DEVELOPMENT INSTITUTE, INC. AT MONTANA STATE UNIVERSITY (US) | 1996-11-19 | — | — | US | disclosed |
| US-3991107-A | Haloamine transfer | NATIONAL PATENT DEVELOPMENT CORPORATION (US) | 1976-11-09 | — | — | US | disclosed |
| US-3943628-A | Spoon excavator for applying chemically acting tooth decay attacking fluid | KRONMAN JOSEPH H | 1976-03-16 | — | — | US | disclosed |